PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
8115030-5	1993	Loxiglumide, (CR 1505), a newly synthesized nonpeptide CCK-A-receptor antagonist, D.L-(3,4-dichlorbenzoilamino)-5-/N-(3-methoxypropyl)-pentylamin o-5-oxo-pentanoi c acid, antagonized both the ACh-releasing effect of CCK and the contractions in a dose-dependent manner.	loxiglumide	0-11	cholecystokinin receptor type A	Cavia porcellus	55-69	
9522034-0	1998	Biochemical and pharmacological profiles of loxiglumide, a novel cholecystokinin-A receptor antagonist.	loxiglumide	44-55	cholecystokinin receptor type A	Cavia porcellus	65-91	
9522034-7	1998	These results indicate that the affinity of loxiglumide to CCK-A receptor is at least 63 times greater than that to CCK-B/gastrin receptors.	loxiglumide	44-55	cholecystokinin receptor type A	Cavia porcellus	59-73